Clinical Trial Update: Pharmacokinetics of Sirolimus and Tacrolimus in Liver Transplant Recipients With Tacrolimus Toxicity [Phase 2, Phase 3]

View source ↗

Summary

A trial evaluating the pharmacokinetics of sirolimus and tacrolimus in liver transplant recipients with tacrolimus toxicity has terminated after Phase 2/Phase 3…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Sirolimus (Sirolimus)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: University of Pittsburgh | Conditions: Hypertension | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2016-04-21